ANZCTR12621001646831

Gastroparesis symptoms and its treatment using low-viscosity soluble dietary fibres

The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study
Western Sydney University·Not Applicable·Australian New Zealand Clinical Trials Registry·otherCompleted
Study focus
Disease/Condition
Gastroparesis
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Western Sydney University
Location
Australia
Timeline & enrollment
Phase
Not Applicable
Start date
Jul 02, 2018
End date
Feb 05, 2020
Primary outcome

To compare the blood glucose regulation / control ability of 'low-viscosity' test fibres Partially-hydrolysed guar gum (PHGG) and Gum Arabic to the negative control (Water) and positive control (Psyllium Husk). The blood glucose control of the interventions was assessed using pin-prick blood glucose values in response to the interventions, Actilax and the glucose challenge (50 g in 300 mL).;; To compare the symptom severity / tolerability of 'low-viscosity' test fibres Partially-hydrolysed guar gum (PHGG) and Gum Arabic to the negative control (Water) and positive control (Psyllium Husk). The tolerability of the interventions was assessed using the patient-rated American Neurogastroenterology and Motility Society - Gastroparesis Cardinal Symptom Index - Daily Diary (ANMS-GCSI-DD) in response to the interventions, Actilax and the glucose challenge (50 g in 300 mL).

Summary

The principal aim of this clinical study was to determine the short-term blood-glucose control and tolerability of Partially-hydrolysed guar gum (PHGG) and Gum Arabic in mild-to-moderate symptom gastroparesis patients. There were four interventions in total, the test fibres PHGG and Gum Arabic, the positive control Psyllium Husk and the negative control Water. The study hypothesizes that the 'low-viscosity' test fibres PHGG and Gum Arabic provide blood glucose regulation / control comparable to the positive control, Psyllium Husk, while causing fewer severe symptoms comparable to the negative control, Water.

ICD-10 classifications
Attention to gastrostomyGastrostomy statusOther gastritisGastritis, unspecifiedGastric diverticulum
Data source
Registry
Australian New Zealand Clinical Trials Registry
Trial ID
ANZCTR12621001646831
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for ANZCTR12621001646831 through Pure Global AI's free database. This Not Applicable trial is sponsored by Western Sydney University and is currently Completed. The study focuses on Gastroparesis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.